These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 38328436)

  • 1. Unveiling diagnostic and therapeutic strategies for cervical cancer: biomarker discovery through proteomics approaches and exploring the role of cervical cancer stem cells.
    Jafari A; Farahani M; Abdollahpour-Alitappeh M; Manzari-Tavakoli A; Yazdani M; Rezaei-Tavirani M
    Front Oncol; 2023; 13():1277772. PubMed ID: 38328436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics approaches in cervical cancer: focus on the discovery of biomarkers for diagnosis and drug treatment monitoring.
    Kontostathi G; Zoidakis J; Anagnou NP; Pappa KI; Vlahou A; Makridakis M
    Expert Rev Proteomics; 2016 Aug; 13(8):731-45. PubMed ID: 27398979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics-Driven Biomarkers in Pancreatic Cancer.
    Ramalhete L; Vigia E; Araújo R; Marques HP
    Proteomes; 2023 Aug; 11(3):. PubMed ID: 37606420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
    de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
    Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review.
    Arip M; Tan LF; Jayaraj R; Abdullah M; Rajagopal M; Selvaraja M
    Discov Oncol; 2022 Sep; 13(1):91. PubMed ID: 36152065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer stem cells: opportunities and challenges.
    Chhabra R
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1889-97. PubMed ID: 25563493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
    Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
    J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding Cervical Cancer through Proteomics.
    Martínez-Rodríguez F; Limones-González JE; Mendoza-Almanza B; Esparza-Ibarra EL; Gallegos-Flores PI; Ayala-Luján JL; Godina-González S; Salinas E; Mendoza-Almanza G
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of oncoproteomics to cancer biomarker discovery.
    Cho WC
    Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer.
    Sudhalkar N; Rathod NP; Mathews A; Chopra S; Sriram H; Shrivastava SK; Goda JS
    Cancer Rep (Hoboken); 2019 Apr; 2(2):e1144. PubMed ID: 32721115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in cervical cancer.
    Yim EK; Park JS
    Biomark Insights; 2007 Feb; 1():215-25. PubMed ID: 19690652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer elimination in Italy: Current scenario and future endeavors for a value based prevention.
    Calabrò GE; Riccardi MT; D'Ambrosio F; Castagna C; Sapienza M; Millevolte R; Pellacchia A; Ricciardi R; de Vincenzo RP; de Waure C
    Front Public Health; 2022; 10():1010237. PubMed ID: 36530690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers.
    Martin CM; Kehoe L; Spillane CO; O'Leary JJ
    Mol Diagn Ther; 2007; 11(5):277-90. PubMed ID: 17963416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer.
    Mukherjee A; Pednekar CB; Kolke SS; Kattimani M; Duraisamy S; Burli AR; Gupta S; Srivastava S
    Proteomes; 2022 Apr; 10(2):. PubMed ID: 35645371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspective on cervical cancer: why prevent?
    Morrow CP; Cozen W
    J Cell Biochem Suppl; 1995; 23():61-70. PubMed ID: 8747379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary biomarkers in prostate cancer detection and monitoring progression.
    Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
    Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proteomics and biomarkers for detection of cervical cancer].
    Kacerovský M; Tosner J
    Ceska Gynekol; 2009 Oct; 74(5):335-8. PubMed ID: 20063836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of COPA as a potential prognostic biomarker and pharmacological intervention target of cervical cancer by quantitative proteomics and experimental verification.
    Bao H; Li X; Cao Z; Huang Z; Chen L; Wang M; Hu J; Li W; Sun H; Jiang X; Mei P; Li H; Lu L; Zhan M
    J Transl Med; 2022 Jan; 20(1):18. PubMed ID: 34991628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer.
    Corbo C; Cevenini A; Salvatore F
    Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.